Bentham Science Logo

Track Your Manuscript:


Current Radiopharmaceuticals

Volume 14, 4 Issues, 2021
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access

Contents

Current Radiopharmaceuticals, Volume 11 - Number 3



Review Article   Open Access

Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 11(3): 156 - 172

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*


DOI: 10.2174/1874471011666180416161908






Review Article   Open Access

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 11(3): 200 - 208

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524



Review Article

Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

, 11(3): 209 - 214

George Sgouros*, Robert Hobbs and Anders Josefsson


DOI: 10.2174/1874471011666180426130058



Research Article

In vivo Evaluation of Free and Chelated Accelerator-produced Actinium- 225 - Radiation Dosimetry and Toxicity Results

, 11(3): 215 - 222

Zewei Jiang, Ekaterina Revskaya, Darrell R. Fisher and Ekaterina Dadachova*


DOI: 10.2174/1874471011666180423120707



Research Article

In vivo Evaluation of [225Ac]Ac-DOTAZOL for α-Therapy of Bone Metastases

, 11(3): 223 - 230

Nina Pfannkuchen, Nicole Bausbacher, Stefanie Pektor, Matthias Miederer and Frank Rosch*


DOI: 10.2174/1874471011666180604083911






Editor-in-Chief

Andrea Ciarmiello
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Radiopharmaceuticals was launched in 2008 with the assistance of Dr. Sean L. Kitson who served as the Editor-in-Chief of the journal till 2021. The current Editor-in-Chief, Prof. Dr. Andrea Ciarmiello, took charge of the journal from June 2021.

Related Journals

Related eBooks

eBooks Catalog